Dollar bond market needs shot in the arm from AbbVie
The prospect of a blockbuster bond deal from US pharmaceutical group AbbVie was welcomed by dollar bond investors this week, after corporate issuance tumbled to its lowest monthly tally this year.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: